BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190607
DTSTAMP:20260411T043914
CREATED:20190201T195534Z
LAST-MODIFIED:20190214T191645Z
UID:2275-1559520000-1559865599@carb-x.org
SUMMARY:2019 BIO International Convention
DESCRIPTION:The BIO International Convention (BIO) attracts 16\,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery\, biomanufacturing\, genomics\, biofuels\, nanotechnology and cell therapy. \nThe key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering\, exposure to industry thought-leaders with over 500 education sessions at your fingertips\, and unparalleled networking opportunities with 16\,000+ attendees from 67 countries. \nSee the schedule here.
URL:https://carb-x.org/event/2019-bio-international-convention/
LOCATION:Philadelphia Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190604T133000
DTEND;TZID=Europe/Berlin:20190604T150000
DTSTAMP:20260411T043914
CREATED:20190528T155449Z
LAST-MODIFIED:20190528T160555Z
UID:3052-1559655000-1559660400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Mining Chemical Libraries for New Antibacterials - Session 2
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar the recording of Carl Balibar’s presentation ‘Mining of chemical libraries for new antibacterials’ (original webinar on 21 May) will be followed by another live Q&A session with Carl. \nDespite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nSpeakers:\nCarl Balibar\, Principal Scientist\, Merck Research Laboratories \nModerator:\nBenjamin Blasco\, Discovery Senior Project Manager\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials-session-2/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR